BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31603760)

  • 21. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.
    Petrakis IL; Leslie D; Rosenheck R
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1780-4. PubMed ID: 14634494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between medication adherence and treatment outcomes: the COMBINE study.
    Zweben A; Pettinati HM; Weiss RD; Youngblood M; Cox CE; Mattson ME; Gorroochurn P; Ciraulo D
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1661-9. PubMed ID: 18616687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of drugs for alcohol use disorder in Norway 2004–16].
    Heldal AT; Skurtveit S; Lobmaier PPK; Vederhus JK; Bramness JG
    Tidsskr Nor Laegeforen; 2018 Nov; 138(18):. PubMed ID: 30421743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    Kranzler HR; Soyka M
    JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choosing the right medication for the treatment of alcoholism.
    Pettinati HM; Rabinowitz AR
    Curr Psychiatry Rep; 2006 Oct; 8(5):383-8. PubMed ID: 16968619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging approaches to managing alcohol dependence.
    Swift R
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
    Johnson BA
    Biochem Pharmacol; 2008 Jan; 75(1):34-56. PubMed ID: 17880925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication treatment for alcohol use disorder in special populations.
    Malhotra A; Drexler K; Hsu M; Tang YL
    Am J Addict; 2023 Sep; 32(5):433-441. PubMed ID: 37551638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
    Muvvala SB; O'Malley SS; Rosenheck R
    Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to extended release naltrexone: Patient and treatment characteristics.
    Chang G; Crawford M; Pitts M; Schein AZ; Goodwin K; Enggasser JL
    Am J Addict; 2018 Sep; 27(6):524-530. PubMed ID: 30106489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
    Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
    Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
    Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.
    Del Re AC; Gordon AJ; Lembke A; Harris AH
    Addict Sci Clin Pract; 2013 Jul; 8(1):12. PubMed ID: 23835352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
    Arias AJ; Gelernter J; Gueorguieva R; Ralevski E; Petrakis IL
    Am J Addict; 2014; 23(3):288-93. PubMed ID: 24724887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder.
    Warren D
    FP Essent; 2019 Mar; 478():30-42. PubMed ID: 30844223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany - Analysis of Data of A Statutory Health Insurance.
    Scherbaum N; Holzbach R; Stammen G; Kirchof U; Bonnet U
    Pharmacopsychiatry; 2020 Jan; 53(1):37-39. PubMed ID: 31132796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.